Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) - Cash on Hand
Cash on Hand as of December 2023 : $63.61 M
According to Prestige Consumer Healthcare's latest financial reports the company has $63.61 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Prestige Consumer Healthcare - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $58.48 M | 115.15% |
| 2022-03-31 | $27.18 M | -15.84% |
| 2021-03-31 | $32.3 M | -65.91% |
| 2020-03-31 | $94.76 M | 244.21% |
| 2019-03-31 | $27.53 M | -15.42% |
| 2018-03-31 | $32.54 M | -22.24% |
| 2017-03-31 | $41.85 M | 53.71% |
| 2016-03-31 | $27.23 M | 27.73% |
| 2015-03-31 | $21.31 M | -24.75% |
| 2014-03-31 | $28.33 M | 80.8% |
| 2013-03-31 | $15.67 M | -17.59% |
| 2012-03-31 | $19.01 M | 42.61% |
| 2011-03-31 | $13.33 M | -67.55% |
| 2010-03-31 | $41.09 M | 16.82% |
| 2009-03-31 | $35.18 M | 478.83% |
| 2008-03-31 | $6.07 M | -55.82% |
| 2007-03-31 | $13.75 M | 67.78% |
| 2006-03-31 | $8.2 M | 53.73% |
| 2005-03-31 | $5.33 M | 57.21% |
| 2004-03-31 | $3.39 M | -3.88% |
| 2003-03-31 | $3.53 M | -55.23% |
| 2002-03-31 | $7.88 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 41,113.55% | 🇺🇸 USA |
 Procter & Gamble PG | $6.82 B | 10,633.32% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 15,138.54% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 19,848.13% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 11,342.27% | 🇺🇸 USA |
 Clorox CLX | $0.21 B | 244.26% | 🇺🇸 USA |
 CVS Health CVS | $13.08 B | 20,475.34% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $5.17 B | 8,034.81% | 🇬🇧 UK |
 Rite Aid
RAD | $92.92 M | 46.08% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $0.90 B | 1,318.24% | 🇮🇱 Israel |